Fresh2 Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FRES research report →
Price Chart
About the company
Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co. , Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients.
- CEO
- Haohan Xu
- IPO
- 2020
- Employees
- 75
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on FRES
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.08M
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 1.16
- P/B
- -0.00
- EV/EBITDA
- -0.24
- Div Yield
- 0.00%
- Gross Margin
- 69.21%
- Op Margin
- -870.20%
- Net Margin
- -846.01%
- ROE
- 1121.57%
- ROIC
- -2573.82%
Latest fiscal year · YoY change
- Revenue
- $12.04M-33.0%
- Gross Profit
- $8.34M-32.0%
- Op Income
- $-104,807,000
- Net Income
- $-101,893,000+14.2%
- EPS
- $-106578.00+69.1%
- OCF Growth
- +22.2%
- FCF Growth
- +24.2%
- 52W High
- $9.00
- 52W Low
- $0.73
- 50D MA
- $1.06
- 200D MA
- $2.29
- Beta
- 1.28
- RSI (14)
- 34
- Avg Volume
- 17.45K
No earnings-call transcripts are available for FRES yet.
- Free Float
- 100.0%
- Shares Outstanding
- 12.27K
- Float Shares
- 12.27K
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 20 ETFs
Biggest fund positions in FRES by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 1, 24 | Liang Zhijun | other | 0 |
| Mar 11, 24 | Zhao Zhigang | other | 100,000 |
| Apr 14, 25 | Li Xiaoyu | other | 471,695 |
| Mar 11, 24 | Pu Tianruo | other | 100,000 |
| Mar 11, 24 | Tian Honggang | other | 100,000 |
| Jan 1, 24 | Xu Haohan | other | 0 |
| Jan 1, 24 | Xu Haohan | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FRES coverage
Recent articles, reports, and earnings notes.
Want a deeper read on FRES?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Miners lead FTSE 100 risers as copper hits two-week high on supply squeeze
proactiveinvestors.co.uk · Jun 2
FTSE 350 precious metals miners slide as gold and silver prices retreat
proactiveinvestors.co.uk · Mar 19
Precious metals miners well bid as Iran strikes stock safe haven gold demand
proactiveinvestors.co.uk · Mar 2
Gold mining stocks singled out as investment bank lifts gold forecast
proactiveinvestors.co.uk · Feb 25
Gold, silver, copper and bitcoin prices rise as markets embrace more risk
proactiveinvestors.co.uk · Nov 10
Gold sell-off continues with 11% plunge from record highs
proactiveinvestors.co.uk · Oct 28
Gold miners hit highs as metal's price nears $3,700 an ounce
proactiveinvestors.co.uk · Sep 16
London-listed precious metals stocks gain as gold heads for fourth weekly rise
proactiveinvestors.co.uk · Sep 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.